The proposed acquisition terms grant RXO shareholders $17.25 in cash plus 0.0856 shares of C.H. Robinson Worldwide stock for each share held. Ademi LLP is currently reviewing the transaction to determine if these terms adequately reflect RXO's long-term growth prospects or if the board failed to prioritize the interests of public shareholders during negotiations.
Ademi LLP Launches Investigation Into $5.8 Billion RXO Buyout
A $5.8 billion deal to acquire RXO Inc. faces legal scrutiny as Ademi LLP probes whether the $30.25 per share consideration offers fair value to public investors. The investigation centers on potential conflicts of interest, board conduct, and contractual barriers that may stifle competitive bidding for the company.
Key areas of concern include substantial change-of-control payouts reserved for company insiders and restrictive provisions, such as significant termination penalties, that could discourage superior offers from third parties. Shareholders are being encouraged to come forward to discuss their rights, as the firm examines whether the board fulfilled its fiduciary obligations throughout the deal-making process.
Comments (0)
No comments yet. Be the first!